According to Tongce Medical's announcement, Baoqun Industrial, the controlling shareholder of the company, pledged 21.66 million shares, accounting for 14.29% of the company's shares and 4.87% of the company's total share capital. The pledged financing was used for out-of-system medical projects; during the same period, 21.66 million pledged shares were processed, accounting for 14.29% of the company's shares and 4.87% of the company's total share capital. After this change, Baoqun Industrial pledged a total of 1006.886.72 million shares, accounting for 66.42% of its shares and 22.65% of the company's total share capital; Baoqun Industrial and its co-actors pledged 65.52% of the total shares, accounting for 22.65% of the company's total share capital. The pledge risk is manageable and will not lead to a change in the company's actual control.

According to Tongce Medical's announcement, Baoqun Industrial, the controlling shareholder of the company, pledged 21.66 million shares, accounting for 14.29% of the company's shares and 4.87% of the company's total share capital. The pledged financing was used for out-of-system medical projects; during the same period, 21.66 million pledged shares were processed, accounting for 14.29% of the company's shares and 4.87% of the company's total share capital. After this change, Baoqun Industrial pledged a total of 1006.886.72 million shares, accounting for 66.42% of its shares and 22.65% of the company's total share capital; Baoqun Industrial and its co-actors pledged 65.52% of the total shares, accounting for 22.65% of the company's total share capital. The pledge risk is manageable and will not lead to a change in the company's actual control.